
A healthier world through Taiwan's proven healthcare model
At the 77th World Health Assembly, members adopted the World Health Organisation (WHO) Fourteenth General Programme of Work for 2025-2028.
The programme includes such strategic objectives as improving health service coverage and bolstering financial protections to ensure universal health coverage.
WHO has called on all countries to take action on these issues.
As concerns rise over universal health coverage, Taiwan launched the National Health Insurance (NHI) system in 1995. The scheme, which brought together already existing occupational insurance schemes, has reached its 30th year and now covers 99.9 per cent of the population.
The NHI system provides equitable, accessible, and efficient healthcare to all people in Taiwan. It is also an important pillar and guarantor of Taiwan's social stability as well as people's health and safety.
It has, moreover, become a global benchmark for achieving universal health coverage. In an annual survey carried out by Numbeo, Taiwan has been ranked first in the Health Care Index category for seven consecutive years.
The NHI operates on a pay-as-you-go, self-sustaining model capable of addressing the financial challenges posed by an ageing population and rising healthcare costs.
By reforming premium rates and adding additional funding sources, such as the tobacco health and welfare surcharge, the system is on a sound, sustainable footing.
To promote the health of our people, President Lai Ching-te articulated a vision of a healthy Taiwan in 2024. This aims to ensure that people are healthy, the nation is strong, and the world is more ready to embrace Taiwan.
Remaining focused on people, families, and communities, we are expanding health promotion operations and preventive healthcare.
Moreover, we are implementing a family physician plan, offering comprehensive care to patients with chronic diseases, and utilising telemedicine to improve healthcare accessibility in rural areas.
By promoting integrated long-term care, palliative care, and ageing in place, we ensure holistic, lifelong, and dignified care for all people, realising health equity.
In 2021, WHO released the Global Strategy on Digital Health for 2020-2025. Under this plan, the global health body is seeking the development and adoption of person-centric digital health solutions to prevent, detect, and respond to infectious diseases.
It is also overseeing development of infrastructure and applications to use health data to promote health and well-being.
Taiwan continues to utilise its prowess in information and communications technology to build effective, high-ROI health systems and services.
The NHI cloud facilitates the more efficient exchange of medical records, while the adoption of international standards such as Fast Healthcare Interoperability Resources enhances international medical data sharing.
Additionally, the incorporation of AI-assisted technologies is advancing the development of smart healthcare. And the introduction of a virtual health insurance card and the My Health Bank app, which enables real-time management of personal health data, empowers people to make health-enabling choices.
In 2008, Taiwan introduced the Health Technology Assessment to facilitate evidence-based policymaking. It also accelerated the inclusion of new treatments under the NHI system.
For example, in 2023, gene and cell therapies were covered for the first time, marking a new era for precision medicine and offering patients enhanced treatment options.
Taiwan also continues to leverage innovative technologies to improve the working environment for the medical workforce and to bolster the overall quality of medical service.
What's more, despite facing political challenges, Taiwan has continuously participated in international health affairs and has been dedicated to supporting the global health system.
During the Covid-19 pandemic, Taiwan played a crucial role in sharing supplies, strategies, and experiences, and proved to be a reliable partner of countries worldwide.
Separately, Taiwan's success story in implementing universal health coverage offers valuable lessons for countries worldwide.
As we continue to share our experiences in universal coverage, financial management, and digital health, we hope to facilitate other nations in reaching WHO's goal of universal health coverage.
In this rapidly changing era, health challenges transcend borders, and global cooperation has become essential to addressing various health crises.
However, Taiwan has been prevented from participating in WHO—the foremost global health cooperation body—due to China's continued distortion of United Nations General Assembly Resolution 2758 and World Health Assembly Resolution 25.1.
Neither of these resolutions mentions Taiwan or declares that Taiwan is part of the People's Republic of China. Therefore, these resolutions have no power to confer upon the PRC any right to represent Taiwan in WHO.
In light of this, and to uphold the core UN values of inclusiveness and universality, we urge WHO and all relevant parties to recognise Taiwan's considerable contributions to global public health and the human right to health.
It is imperative that WHO adopt a more open-minded approach and demonstrate flexibility, adhering to the principles of professionalism and inclusivity.
Taiwan should be included, as a matter of pragmatism, in the World Health Assembly and all WHO meetings, activities, and mechanisms, particularly those concerned with the WHO pandemic agreement.
Taiwan earnestly hopes to work with the international community to create a future of borderless healthcare that realises the fundamental human right to health stipulated in the WHO Constitution and the vision of leaving no one behind espoused in the UN Sustainable Development Goals.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Sun
7 hours ago
- The Sun
HOPE Foundation and Taiwan's Top Lung Cancer Experts Call for Seamless Integration of Early Screening, Precision Diagnostics, and Early Treatment
TAIPEI, TAIWAN - Media OutReach Newswire - 16 August 2025 - Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Yet, progress is within reach. In Taiwan, thanks to the National Lung Cancer Early Detection Program, the proportion of early-stage lung cancer cases continues to rise. Against this backdrop, HOPE Foundation for Cancer Care, one of the largest cancer-focused patient advocacy groups in Taiwan, recently hosted a press conference titled 'Healthy Taiwan, Leading the World – Ushering in a New Era of Early Screening and treatment of Lung Cancer'. The event brought together distinguished government officials, ten leading medical authorities in lung cancer, and renowned lung cancer experts from major medical centers nationwide to chart the next phase of early lung cancer prevention and control policies. United in their commitment, participants advocated for the seamless integration of early screening, precision diagnostics, and early treatment in lung cancer care, strengthening efforts to promote early detection and intervention. Ultimately, aiming to support Taiwan in achieving its ambitious goal of reducing cancer mortality rates by one-third by 2030, setting a new international benchmark in cancer control. Taiwan's proactive approach to lung cancer prevention is recognized globally for its vision and effectiveness. In July 2022, the government launched the Lung Cancer Early Detection Program, offering biannual low-dose CT (LDCT) screenings for high-risk groups, including those with a family history of lung cancer and heavy smokers. This pioneering initiative has positioned Taiwan as an international role model in lung cancer prevention. Over the past three years, more than 210,000 screenings have led to the identification of 2,506 lung cancer cases—over 80% of which were diagnosed at an early stage, with late-stage diagnoses dropping sevenfold. Previously, late-stage diagnosis was the norm, but Taiwan's proactive policies have transformed the landscape, reversing the trend and ensuring that most initial lung cancer cases are now detected early. During his recent visit to Taiwan, Dr. Cary Adams, CEO of the Union for International Cancer Control (UICC), commended Taiwan's National Cancer Control Program, its comprehensive cancer registry, and robust National Health Insurance (NHI) system for establishing an exemplary cancer care network. He encouraged Taiwan to further improve early lung cancer screening rates and timely access to treatment, reinforcing its status as a global public health leader. At the conference, Minister of Health and Welfare Dr. Chiu Tai-Yuan pledged ongoing cross-ministerial collaboration and policy innovation to improve early lung cancer detection and treatment. Legislator Wang Cheng-Hsu also reaffirmed his commitment to early detection and intervention, advocating for increased resources and improved legislation to ensure early-stage lung cancer patients receive comprehensive care. Leading medical experts further emphasized Taiwan's advancements. Dr. Yang, Pan-Chyr, Academician of Academia Sinica, highlighted how the LDCT screening program has driven a shift toward earlier-stage diagnosis, with research indicating it could reduce lung cancer mortality by 53%. Dr. Chen Chien-Jen, Academician of Academia Sinica emphasized that the next key challenge is ensuring early-stage patients benefit from precision diagnostics and early treatment. Dr. Yang Cheng-Ta, President of the Taiwan Lung Cancer Society, added that emerging AI technology is now capable of analyzing LDCT images to predict an individual's six-year cancer risk, which will improve identification of high-risk groups and support early intervention. Dr. Yang Chih-Hsin, President of Taiwan Association for the Study of Lung Cancer, urged early-stage patients to undergo genetic testing promptly, enabling medical teams to tailor optimal treatment plans, including surgery, targeted therapy, or immunotherapy as adjuvant treatments. HOPE called for NHI resources to shift toward early lung cancer diagnosis and treatment, highlighting the importance of genetic testing and adjuvant therapy for high-risk early-stage patients to reduce relapse and mortality. Clinical evidence shows that adjuvant targeted therapy after surgery for stage IB–IIIA lung cancer with EGFR mutations can reduce five-year mortality by 10%, which is vital for improving outcomes and easing the burden on the healthcare system. Dr. Chen Jin-Shing, Head of Thoracic Surgery Division at National Taiwan University Hospital, advocated for priority reimbursement of adjuvant targeted therapy for patients with stage IB-IIIA lung cancer, while Dr. Chen Chih-Yi, Board Member of HOPEemphasized the importance of improving access to early genetic testing and treatment. Dr. Huang, Ming-Shyan, President of the Taiwan Clinical Oncology Society, pointed out that early-stage lung cancer treatment in Taiwan is not yet fully aligned with international guidelines, and urged that expanded screening must be matched with optimized NHI resource allocation and improved treatment access. Other leading voices reinforced the need for comprehensive care. Dr. Wang Chin-Chou, Board Member of Taiwan Society of Pulmonary and Critical Care Medicine, stressed that while surgery is the primary treatment for early-stage lung cancer, it must be accompanied by proactive adjuvant therapy strategies and long-term follow-up. Dr. Chang Wen-Cheng, CEO of Taiwan Cancer Foundation emphasized that the integration of screening, diagnosis, and treatment is crucial to truly realize early detection and treatment, as well as maximizing the value of screening program. Dr. Chen Jen-Shi, President of Taiwan Oncology Society, recommended that in addition to current NHI and Cancer Drug Fund financing, the government should promote diverse payment mechanisms—such as co-payment models or commercial insurance to supplement the NHI system—to further improve access to early lung cancer treatment. Uniting multiple lung cancer treatment experts from medical centers across Taiwan, a concerted effort to usher in a new era of early lung cancer screening and treatment. (Listed by institution from North to South) · Dr. Chen Yu-Min, Director of General Chest Medicine Department, Taipei Veterans General Hospital · Dr. Lee Kang-Yun, Attending Physician, Division of Pulmonary Medicine, Shuang Ho Hospital · Dr. Huang Chun-Yao, Attending Physician, Division of Chest Medicine, Taipei Tzu Chi Hospital · Dr. Tsai Chen-Liang, Director of Pulmonary and Critical Care Medicine Division, Tri-Service General Hospital · Dr. Yeh Yu-Wen, Physician, Division of Thoracic Medicine, Shin Kong Wu Ho-Su Memorial Hospital · Dr. Chang Sheng-Yu, Attending Physician and Leader of the Lung Cancer Team, Far Eastern Memorial Hospital · Dr. Yang Tsung-Ying, Director of General Chest Medicine Department, Taichung Veterans General Hospital · Dr. Hsia Te-Chun, Deputy Director, Department of Internal Medicine, China Medical University Hospital · Dr. Lin Chien-Chung, Attending Physician, Division of Chest Medicine, National Cheng Kung University Hospital


Sinar Daily
20 hours ago
- Sinar Daily
Conceiving with Care: Using fertility medicines the right way
FERTILITY struggles are becoming more common, affecting around onein sixcouples. In Malaysia, the total fertility rate (TFR) fell to 1.73 children per woman in 2023, far below the population replacement rate of 2.1. The lower fertility rate is commonly associated with reduced population growth and can be attributed to various social, economic and health-related influences, including greater educational attainment, increased workforce participation especially among women and evolving perceptions of ideal family size. DEFINITION AND CAUSES FOR INFERTILITY The World Health Organisation (WHO) defines infertility as the inability to conceive after one year of regular, unprotected sexual intercourse. Infertility can affect both women and men, and there are several possible causes, including: Ovulation disorders, which may be due to polycystic ovary syndrome (PCOS), hormonal imbalances, or previous ovarian surgery Blocked fallopian tubes, often resulting from sexually transmitted infections, or endometriosis The presence of cysts or fibroids within the uterine cavity Abnormal or poor-quality sperm caused by congenital abnormalities, or hormonal issues Infections in the testicles, undescended testicles, or varicocele (enlarged veins in the scrotum) Excess body weight Smoking habits Frequent exposure to radiation or harmful chemicals But, in some cases, infertility has no identifiable cause and is classified as unexplained infertility. COMMONLY PRESCRIBED MEDICINES FOR INFERTILITY Fertility medicines such as clomiphene, gonadotropins and bromocriptine are frequently prescribed by doctors to act like the body's natural hormones, such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These medicines are primarily indicated for the treatment of infertility in women, especially in cases involving ovulation disorders. They help to produce better quality eggs or increase the number of eggs released. However, not all infertility cases can be treated with medicines alone. Certain conditions, such as blocked fallopian tubes, structural abnormalities or severe male factor infertility, may require other interventions like surgery or assisted reproductive technologies. Although there are several medicine options available to help with infertility, patients should not take them without a doctor's advice. Taking these medicines without supervision from a healthcare professional can be harmful to the patient. Like other medicines, fertility medicines can cause side effects too. Thus, their use must be closely monitored to minimiSe the risks. For example, clomiphene is commonly used as the first line treatment to induce ovulation. However, it may still cause side effects such as hot flashes, mood swings or the development of ovarian cysts if not taken correctly. Gonadotropins, which are given as injections to stimulate the ovaries, carry the risk of ovarian hyperstimulation syndrome (OHSS). This condition can potentially be serious and causes the ovaries to become swollen and painful. Another medicine, bromocriptine, is used to lower elevated prolactin levels that can disrupt ovulation and lead to infertility. However, it may cause side effects such as dizziness, headaches, vomiting or constipation. A mother looks after her newborn baby in hospital in Nantes, western France, on July 8, 2018. (Photo by LOIC VENANCE/AFP) ADVICE FOR INDIVIDUALS WITH INFERTILITY The journey to conceive can be challenging and requires patience for some couples. Therefore, those considering fertility treatment should seek accurate information and proper guidance from qualified healthcare professionals. For example, Hospital Tunku Azizah offers a Fertility Medication Therapy Adherence Clinic, which provides comprehensive care and personalised treatment plans to improve fertility outcomes. The clinic is managed by pharmacists working closely with a multidisciplinary team of healthcare professionals. Working with specialists can help identify the most appropriate treatment based on an individual's medical history and health condition, ultimately increasing the chances of conception. In addition, couples are encouraged to undergo a comprehensive health screening to ensure they are in optimal health before starting fertility treatment. During the course of treatment, regular health check-ups are essential to ensure the process proceeds smoothly. Patients who have been prescribed medicines for infertility treatment should take them according to the instructions and advice provided by their doctor or pharmacist. Incorrect usage such as taking the wrong dosage, using inappropriate combinations, or not following the recommended schedule can reduce the effectiveness of treatment, increase the risk of side effects, and potentially cause long-term health complications. Some people turn to over-the-counter supplements like folic acid, vitamin D or antioxidants in the hopes of boosting fertility. However, scientific evidence supporting their effectiveness remains limited. These supplements may benefit overall health, but they should not replace medical treatments or be relied upon as the sole solution for fertility issues. Couples are also encouraged to adopt a healthy lifestyle by maintaining a balanced diet, exercising regularly and getting adequate rest. They should also avoid habits that may affect fertility such as smoking and excessive alcohol consumption. Psychological support from a partner, family or friends, as well as counselling sessions, can help patients cope with the stress that may arise during the treatment process. In conclusion, although infertility can be a complicated and emotionally challenging experience, it is important to remember that help is available. With the right treatment and proper use of prescribed medicines under professional care, many couples have found renewed hope and meaningful progress in their fertility journey. If there are any inquiries regarding medicines, please call the National Pharmacy Call Centre (NPCC) at the toll-free number 1-800-88-6722 during weekdays from 8 a.m. to 5 p.m., except on public holidays. Prepared by Syafi'ah Bakaruddin, Pegawai Farmasi UF12, Klinik Kesihatan Putrajaya Presint 9, Pejabat Kesihatan Putrajaya. She can be contacted at syafiah.b@


The Star
5 days ago
- The Star
More obese children are developing 'adult' diabetes
Twelve-year-old Adam loves his toasted bread coated with condensed milk and a sprinkle of chocolate rice for breakfast. At school, he often grabs fried chicken rice for lunch and a sweet drink on the way home. In the evening, he's glued to his mobile games, snacking on chocolate biscuits. His parents notice he has gained weight and recently tires easily, wakes up at night to pee frequently and constantly asks for water. A visit to the doctor and a simple blood test confirms their fears: Adam has type 2 diabetes. His parents are shocked: 'But he's just a child! Isn't diabetes something only adults get? 'Did we do something wrong?' If these thoughts sound familiar, you're not alone. Unhealthy lifestyle patterns In Malaysia, nearly one in three children is either overweight or obese, according to a 2022 review in the Malaysian Journal of Nutrition. Globally, the World Health Organization (WHO) estimates that around one in five children and adolescents aged five to 19 years are overweight, with 8% classified as obese. With this rising trend comes a worrying increase in young patients presenting with prediabetes or full-blown type 2 diabetes – a condition once considered exclusive to adults.. So why is this happening? Type 2 diabetes tends to run in families due to a combination of shared genetic factors and lifestyle habits, such as eating patterns and physical activity levels, that increase the risk among close relatives. The main lifestyle contributors are: Unhealthy diets Processed, sugary, and fried foods are often more accessible and cheaper than healthy alternatives. Many children exceed the recommended daily sugar limit. Sedentary lifestyle In previous generations, walking to school or playing outside was normal. But children today spend hours indoors on screens: YouTube, mobile games and social media. Outdoor play and physical activities have become rare in their daily routine. Poor sleep routines Staying up late while staring at a screen affects melatonin and cortisol levels, increasing cravings for sugary or fatty foods, which leads to weight gain and insulin resistance. Causing insulin resistance Obesity, especially central obesity (fat stored around the abdomen), plays a key role in the development of type 2 diabetes. Preventing type 2 diabetes can involve steps as simple as cutting back on sugary drinks and getting children used to drinking plain water as their default beverage. This excess adiposity causes the body to become resistant towards the actions of insulin, which is being produced normally by our body. The result is that glucose (sugar) builds up in the blood. Our pancreas then tries to compensate by producing more insulin to overcome this 'resistance'. Over time, the pancreas becomes 'exhausted', and blood sugar levels start to rise. This is the beginning of type 2 diabetes. Many people think diabetes only becomes dangerous later in life, but in reality, children with type 2 diabetes are at risk of both acute and long-term complications. Acutely, they may develop life-threatening conditions like diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS). Both these conditions can lead to severe dehydration, organ failure, and even coma, if not treated promptly. Long-term complications, once seen mostly in older adults, can also appear earlier in young people living with type 2 diabetes, including: Nerve damage (neuropathy) – causing tingling, numbness or burning pain. Eye problems – such as diabetic retinopathy, which may lead to blindness. Kidney damage – diabetic nephropathy, which can lead to kidney failure. Heart disease and high blood pressure – increasing risk of heart attacks and strokes, even from a young age. Predisposition to infections. Spotting the warning signs Unlike type 1 diabetes, which develops quickly and dramatically, type 2 diabetes in children often develops silently and gradually, making it harder to detect. Watch for these red flags: Frequent thirst and urination Tiredness, even with adequate sleep Weight changes – either rapid gain or unexplained loss Dark velvety patches on the neck, armpits or elbows – this is a sign of insulin resistance known as acanthosis nigricans Recurrent infections or slow-healing wounds Mood swings or irritability. A simple fasting blood sugar test and HbA1c test at your clinic can reveal whether your child is at risk. Further blood tests such as diabetes antibodies will be done to differentiate between type 1 and type 2 diabetes. Lower your child's risk Type 2 diabetes is manageable, but prevention is best. This doesn't mean forcing your child into a strict diet or intense workouts. Small, sustainable lifestyle changes can make a big difference – and they work best when the whole family gets involved. These can include: > Cutting back on sugary drinks gradually Instead of a complete ban (which may cause rebellion), start by reducing the frequency of consuming such drinks. Swap syrupy drinks or juices for infused water with lemon or mint if your child wishes for a more 'flavourful' drink. Encourage water as the default drink during meals. Gradually limit sweet drinks like bubble tea, iced chocolate or malted drinks, and fruit-flavoured milk to special occasions only. > Tweak their favourite meals Healthy eating doesn't mean abandoning Malaysian favourites; it's about smart swaps. Choose grilled or baked chicken over deep-fried. Replace white rice with brown rice. Add more vegetables to family dishes like fried rice, curry and soups. Avoid ultra-processed snacks like chips and opt for fruit, yoghurt or nuts. > Encourage active play, not just exercise Many children dislike the idea of 'exercise', but love to play. Try dancing games, cycling, hula-hooping or treasure hunts. Let them choose a weekend activity: sports, hiking or swimming. Revive traditional games like batu seremban, congkak or galah panjang. > Limit screen time without battles You don't have to ban gadgets altogether, but balance is key. Create 'tech-free' zones (e.g. during meals and before bedtime). Use parental controls or timers to limit passive screen time. Pair screen use with movement. > Make it a family affair Children learn by example with a supportive family. When the whole family makes healthier choices, kids follow naturally. Encourage positively. Cook together and let your child choose a veggie to try each week. Go to the market together and teach them about fresh produce. Present food creatively, e.g. use colourful bento boxes or cut fruit into fun shapes. Start small today If your child is overweight or has been diagnosed with prediabetes, don't panic and don't blame yourself. Parenting doesn't come with a manual, and lifestyle changes are often shaped by environment, availability and awareness. What's most important is what you choose to do today. Start small and be consistent. Keep it fun: Movement should be enjoyable, not a punishment. Do it together: When families act as a team, progress is faster and more sustainable. As a paediatric endocrinologist, I've seen how easily type 2 diabetes can creep up. But I've also seen how families who take proactive steps early can turn their child's health around. Let's give our children the best chance at a healthy, happy life one small step at a time with no blame or shame. Worried about your child's weight or risk of diabetes? Talk to your doctor or a paediatric endocrinologist. Early intervention is the best prevention. Dr Jeanne Wong Sze Lyn is a consultant paediatrician and paediatric endocrinologist. For more information, email starhealth@ The information provided is for educational purposes only and should not be considered as medical advice. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this column. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.